Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COBRRA-AF: Apixaban vs Rivaroxaban in Atrial Fibrillation
NCT04642430Phase 4Recruiting
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Jul 2021
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban, rivaroxaban in Atrial fibrillation (AFib), sponsored by Ottawa Hospital Research Institute. Started Jul 2021; status: recruiting.
02
Drugs
apixabanrivaroxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT04642430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04642430.